SEATTLE–(BUSINESS WIRE)–According to Coherent Market Insights, the global tissue and organ transplantation market is estimated to be valued at US$ 13.9 Billion in 2020 and is expected to exhibit a CAGR of 9.1% during the forecast period (2020-2027).

Key Trends and Analysis of the Global Tissue and Organ Transplantation Market:

The global tissue and organ transplantation market is expected to witness significant growth, owing to increasing R&D activities in tissue transplantation. For instance, in May 2019, researchers from AMALNA Consulting and RMIT University, in collaboration with Tithon Biotech Inc., predicted the characteristic frequencies related to parathyroid hormone activities, particularly differentiation of stem cells into osteoblasts. The research findings can aid in development of improved techniques for differentiation of stem cells in tissue transplantation and repair.

Similarly, in December 2018, the study ‘Pathological Process of Prompt Connection between Host and Donor Tissue Vasculature Causing Rapid Perfusion of the Engineered Donor Tissue after Transplantation’, published in the journal MDPI International Journal of Molecular Sciences, found that donor myocardial cell sheets including endothelial cell networks and potent pericytes could connect to host vasculature causing rapid donor tissue perfusion within 24 hours after transplantation.

Manufacturers are focusing on new product development, mergers & acquisition, and collaborations to expand their current product portfolio and strengthen their market position. For instance, in September 2016, Stryker Corporation acquired Instratek, a leading manufacturer of minimally invasive soft tissue recession instruments for ankle, foot, and upper extremity procedures.

For instance, in September 2015, Arthrex, Inc. launched ArthroFlex Acellular Dermal Matrix, which provides high strength and support to restore stability in capsular reconstruction.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4342

Key Market Takeaways:

The global tissue and organ transplantation market is expected to exhibit a CAGR of 9.1% during the forecast period (2020-2027), owing to the governments and NGOs taking initiatives to encourage people to donate organs. For instance, in April 2020, Human Resource & Services Administration launched Hospital Organ Donor Campaign in the U.S.

North America is expected to be the most lucrative region in the tissue and organ transplantation market due to the rising number of transplants in the U.S. For instance, according to the health resources and service administration, in 2019, a total of 39,718 transplants were performed in the U.S.

Competitive Landscape:

Key players operating in the global tissue and organ transplantation market include CryoLife, Inc., Folio Biosciences, Arthrex, Abbvie, Inc., Zimmer Biomet, Medtronic PLC, Novartis AG, Stryker Corporation, BiolifeSolutions, Inc. , Teva Pharmaceuticals, and Veloxis Pharmaceutical.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4342

Market Segmentation:

  • Global Tissue and Organ Transplantation Market, By Product Type:
    • Tissue Products
    • Preservation Solution
    • Immunosuppressive Drugs
  • Global Tissue and Organ Transplantation Market, By Application:
    • Organ Transplantation
    • Tissue Transplantation
  • Global Tissue and Organ Transplantation Market, By End User:
    • Hospital
    • Transplant Centers
    • Others
  • Global Tissue and Organ Transplantation Market, By Region:
    • North America
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa

Related Market Intelligence Report:

Organ Transplant Immunosuppressant Drugs Market, by Drugs Class (Calcineurin Inhibitors, Antiproliferative Agents, mTOR inhibitor (Mammalian Target of Rapamycin), Steroids, and Immunosuppressant Antibodies ), by Therapeutic Organ Transplant Type (Heart Transplant, Kidney Transplant, Liver Transplant, Lung Transplant, Pancreas Transplant, and Others), by Distribution Channel (Hospitals, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

Read more: https://www.coherentmarketinsights.com/ongoing-insight/organ-transplant-immunosuppressant-drugs-market-2495

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.

Website: https://www.coherentmarketinsights.com

Transplant News Sharing // “Lung Transplants” – Google News from Source www.businesswire.com

You Might Like

Transplant News
Transplant News

Transplant News brings you original and carefully curated aggregate news stories, articles and content that matter to the transplant community, from top publishers around the web. Everything from patient stories, to the latest in transplant innovation, TN is your window into the world of transplantation.